Celldex Therapeutics, Inc. CLDX
Set alert
29.50 USD +0.46 +1.58%
As of Nov 3, 11:19 AM ET
28.67 Day range 29.83
22.10 52-week range 45.14
- YTD
- +8.61%
- 1 year
- +19.19%
- Open
- 29.36
- Prev close
- 29.04
- Mkt cap
- 2.32B
- Vol
- 129.77K
- Avg vol
- 1.34M
- EPS
- -4.35
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 28.67
- High
- 29.83
- Forward P/E
- -6.83
- Beta
- 1.03
- Short ratio
- 4.27
- Inst. own
- 109.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 34.06
- 200-d avg
- 32.65
- 1y target
- 63.07
3M chart
Events in this range
- Aug 6, 2026Earnings: -0.94; estimate -1.06; surprise 11.32%
- Sep 10, 2026Rating: Morgan Stanley · Overweight → Overweight
- Sep 22, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
- Sep 22, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Sep 23, 2026Rating: Morgan Stanley · Overweight → Overweight
- Sep 23, 2026Rating: Leerink Partners · Outperform → Outperform
- Oct 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (11)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 12, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| RSI: Overbought | Aug 5, 2026 | 3 months ago |
Held by funds
119 US ETFs and mutual funds hold CLDX · largest positions
Ownership
Held by insiders 0.27%
Held by institutions 109.99%
Float held by institutions 110.29%
Institutions 344
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Wellington Management Group, LLP | 12.15% | 9,543,671 | 277.15M | Jun 29, 2026 |
| Blackrock Inc. | 8.92% | 7,002,530 | 203.35M | Jun 29, 2026 |
| Kynam Capital Management, LP | 6.78% | 5,322,908 | 154.58M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.97% | 4,685,223 | 136.06M | Jun 29, 2026 |
| State Street Corporation | 4.97% | 3,900,427 | 113.27M | Jun 29, 2026 |
| FMR, LLC | 4.74% | 3,722,888 | 108.11M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 4.82% | 3,783,994 | 109.89M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 2,487,758 | 72.24M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.57% | 2,020,869 | 58.69M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.04% | 1,603,138 | 46.56M | Sep 29, 2026 |
| Vanguard Explorer Fund | 1.84% | 1,447,608 | 42.04M | Jul 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.60% | 1,254,603 | 36.43M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JIMENEZ FREDDY A | General Counsel | Sale | Dec 3, 2025 | 30,796 |
| MARINO JAMES J | Director | Stock Gift | Nov 17, 2024 | 2,204 |
| MARTIN SAMUEL BATES | Chief Financial Officer | Conversion of Exercise of derivative security | Jan 1, 2026 | 32,942 |
| PEPIN RONALD A | Officer | Conversion of Exercise of derivative security | Dec 14, 2025 | 20,097 |
| WRIGHT RICHARD M | Former | Conversion of Exercise of derivative security | Nov 12, 2025 | 20,833 |